Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSIG eye drops in dry eye disease
NCT04510428Phase 2Withdrawn
- Sponsor
- University of Illinois Chicago
- Start
- May 2023
- Primary completion
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Human normal immunoglobulin G in dry eye disease (DED), sponsored by University of Illinois Chicago. Planned start May 2023; status: withdrawn.
02
Drugs
Human normal immunoglobulin G
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04510428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04510428.